Learn about Pfizer’s clinical research that is focused on melanoma, a form of skin cancer.
Despite recent advances in the treatment of melanoma, more options are needed. Pfizer is currently conducting a clinical trial that is looking at whether three study drugs are safe and effective when given together for melanoma that:
- is advanced or metastatic (spread to other parts of the body);
- has a certain type of abnormal gene called “BRAF”
About half of people with metastatic melanoma have the BRAF gene, which causes cancer cells to multiply out of control. Identifying whether a person with melanoma has the BRAF gene is an important way to identify an appropriate treatment.
If you or a loved one are considering taking part in a melanoma clinical trial, find more information below. With your participation, clinical research might help to identify better treatment options for people with melanoma.
Refine your search
About melanoma
Melanoma is a type of skin cancer that begins in the cells that give the skin its color, called melanocytes. Advanced or metastatic melanoma is a serious form of skin cancer that has spread to other parts of the body.
Skin cancers start to form when skin cells are damaged by UV radiation from the sun or tanning beds, causing certain DNA (genes) to become abnormal. About half of people with metastatic melanoma have an abnormal gene called BRAF that causes cancer cells to multiply out of control.